Enanta Pharmaceuticals

^{Priced, Nasdaq: ENTA}

Biotech focused on developing small molecule drugs to use against hepatitis C.

Industry: Health Care

First Day Return: +22.7%

ENTA

Biotech focused on developing small molecule drugs to use against hepatitis C.

IPO News for Enanta Pharmaceuticals

US IPO Weekly Recap: Seven deals price, six new filers 03/25/13
Enanta Pharmaceuticals prices IPO at $14, the low end of the range 03/20/13
9 US IPOs planned for the week of Mar 18 03/18/13

IPO Data
IPO Date	03/20/2013
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$56
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.enanta.com
Headquarters	Watertown, MA, United States
Founded	1996
Employees at IPO	39

IPO News for Enanta Pharmaceuticals

US IPO Weekly Recap: Seven deals price, six new filers 03/25/13
Enanta Pharmaceuticals prices IPO at $14, the low end of the range 03/20/13
9 US IPOs planned for the week of Mar 18 03/18/13

Enanta Pharmaceuticals (ENTA) Performance